WALDENSTROM'S MACROGLOBULINEMIA
Clinical trials for WALDENSTROM'S MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTROM'S MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for WALDENSTROM'S MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to tame rare blood cancer, prepares for future fight
Disease control OngoingThis study tested a two-drug combination (bortezomib and rituximab) as a first treatment for people with Waldenstrom's macroglobulinemia, a rare blood cancer. The main goals were to see if the treatment could control the disease and safely collect patients' own stem cells. These …
Matched conditions: WALDENSTROM'S MACROGLOBULINEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scientists build blood cancer database to unlock future treatments
Knowledge-focused OngoingThis study collects blood and bone marrow samples from people with multiple myeloma and related blood cancers to build a research database. Participants also provide medical history through a questionnaire. The goal is to help scientists understand these diseases better and devel…
Matched conditions: WALDENSTROM'S MACROGLOBULINEMIA
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC